"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

While everybody is innocently telling you how important it is to rest, your body simply refuses to comply and every sleeping ...

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...